Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
11538 | 975 | 32.4 | 60% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
6 | 4 | GASTROENTEROLOGY & HEPATOLOGY//ONCOLOGY//SURGERY | 1371034 |
337 | 3 | IRRITABLE BOWEL SYNDROME//CONSTIPATION//ENTERIC NERVOUS SYSTEM | 37464 |
111 | 2 | IRRITABLE BOWEL SYNDROME//NEUROGASTROENTEROLOGY AND MOTILITY//FUNCTIONAL DYSPEPSIA | 25141 |
11538 | 1 | OPIOID INDUCED CONSTIPATION//METHYLNALTREXONE//OPIOID INDUCED BOWEL DYSFUNCTION | 975 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | OPIOID INDUCED CONSTIPATION | authKW | 1609982 | 6% | 92% | 56 |
2 | METHYLNALTREXONE | authKW | 1313385 | 6% | 71% | 59 |
3 | OPIOID INDUCED BOWEL DYSFUNCTION | authKW | 971768 | 3% | 97% | 32 |
4 | NALOXEGOL | authKW | 688970 | 2% | 100% | 22 |
5 | CONSTIPATION | authKW | 333651 | 17% | 6% | 165 |
6 | ALVIMOPAN | authKW | 255728 | 2% | 39% | 21 |
7 | OXYCODONE NALOXONE | authKW | 184208 | 1% | 59% | 10 |
8 | LAXATIVES | authKW | 147634 | 4% | 11% | 42 |
9 | PERIPHERAL OPIOID ANTAGONIST | authKW | 125267 | 0% | 100% | 4 |
10 | PERIPHERALLY RESTRICTED OPIOID RECEPTOR ANTAGONISTS | authKW | 125267 | 0% | 100% | 4 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 5427 | 44% | 0% | 428 |
2 | Gastroenterology & Hepatology | 2249 | 15% | 0% | 147 |
3 | Health Care Sciences & Services | 1674 | 9% | 0% | 90 |
4 | Anesthesiology | 742 | 6% | 0% | 54 |
5 | Medicine, General & Internal | 511 | 12% | 0% | 117 |
6 | Medicine, Research & Experimental | 335 | 8% | 0% | 78 |
7 | Clinical Neurology | 320 | 9% | 0% | 91 |
8 | Physiology | 204 | 6% | 0% | 58 |
9 | Neurosciences | 100 | 9% | 0% | 83 |
10 | Primary Health Care | 67 | 1% | 0% | 9 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | FUNDESALUD | 62634 | 0% | 100% | 2 |
2 | REG OBSERV PALLIAT CARE EXTREMADURA | 62634 | 0% | 100% | 2 |
3 | PRACT PHARM PHARMACEUT CARE | 41754 | 0% | 67% | 2 |
4 | CHAIR PALLIAT MED | 41462 | 1% | 19% | 7 |
5 | PALLIAT CARE SUPPORT TEAM | 38538 | 0% | 31% | 4 |
6 | CLIN PALLIAT MED | 35228 | 0% | 38% | 3 |
7 | ADV PAIN | 31317 | 0% | 100% | 1 |
8 | AMER PAIN MED | 31317 | 0% | 100% | 1 |
9 | AMER PAIN MED FDN | 31317 | 0% | 100% | 1 |
10 | ANAESTHESIOL INTENS CARE PAIN THER Y PALL | 31317 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF PAIN AND SYMPTOM MANAGEMENT | 10155 | 3% | 1% | 33 |
2 | EUROPEAN JOURNAL OF PHARMACOLOGY | 3948 | 6% | 0% | 60 |
3 | LIFE SCIENCES | 3229 | 5% | 0% | 46 |
4 | JOURNAL OF PALLIATIVE MEDICINE | 2762 | 1% | 1% | 12 |
5 | NEUROGASTROENTEROLOGY AND MOTILITY | 2708 | 2% | 1% | 15 |
6 | JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS | 2446 | 4% | 0% | 41 |
7 | PHARMACOLOGY | 2418 | 2% | 0% | 16 |
8 | THERAPEUTIC ADVANCES IN GASTROENTEROLOGY | 2367 | 0% | 2% | 4 |
9 | ARCHIVES INTERNATIONALES DE PHARMACODYNAMIE ET DE THERAPIE | 1977 | 1% | 1% | 12 |
10 | SCHMERZ | 1800 | 1% | 1% | 8 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | OPIOID INDUCED CONSTIPATION | 1609982 | 6% | 92% | 56 | Search OPIOID+INDUCED+CONSTIPATION | Search OPIOID+INDUCED+CONSTIPATION |
2 | METHYLNALTREXONE | 1313385 | 6% | 71% | 59 | Search METHYLNALTREXONE | Search METHYLNALTREXONE |
3 | OPIOID INDUCED BOWEL DYSFUNCTION | 971768 | 3% | 97% | 32 | Search OPIOID+INDUCED+BOWEL+DYSFUNCTION | Search OPIOID+INDUCED+BOWEL+DYSFUNCTION |
4 | NALOXEGOL | 688970 | 2% | 100% | 22 | Search NALOXEGOL | Search NALOXEGOL |
5 | CONSTIPATION | 333651 | 17% | 6% | 165 | Search CONSTIPATION | Search CONSTIPATION |
6 | ALVIMOPAN | 255728 | 2% | 39% | 21 | Search ALVIMOPAN | Search ALVIMOPAN |
7 | OXYCODONE NALOXONE | 184208 | 1% | 59% | 10 | Search OXYCODONE+NALOXONE | Search OXYCODONE+NALOXONE |
8 | LAXATIVES | 147634 | 4% | 11% | 42 | Search LAXATIVES | Search LAXATIVES |
9 | PERIPHERAL OPIOID ANTAGONIST | 125267 | 0% | 100% | 4 | Search PERIPHERAL+OPIOID+ANTAGONIST | Search PERIPHERAL+OPIOID+ANTAGONIST |
10 | PERIPHERALLY RESTRICTED OPIOID RECEPTOR ANTAGONISTS | 125267 | 0% | 100% | 4 | Search PERIPHERALLY+RESTRICTED+OPIOID+RECEPTOR+ANTAGONISTS | Search PERIPHERALLY+RESTRICTED+OPIOID+RECEPTOR+ANTAGONISTS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | HOLZER, P , (2012) NON-ANALGESIC EFFECTS OF OPIOIDS: MANAGEMENT OF OPIOID-INDUCED CONSTIPATION BY PERIPHERAL OPIOID RECEPTOR ANTAGONISTS: PREVENTION OR WITHDRAWAL?.CURRENT PHARMACEUTICAL DESIGN. VOL. 18. ISSUE 37. P. 6010 -6020 | 71 | 76% | 15 |
2 | LEPPERT, W , (2015) EMERGING THERAPIES FOR PATIENTS WITH SYMPTOMS OF OPIOID-INDUCED BOWEL DYSFUNCTION.DRUG DESIGN DEVELOPMENT AND THERAPY. VOL. 9. ISSUE . P. 2215 -2231 | 67 | 70% | 8 |
3 | GAERTNER, J , SIEMENS, W , CAMILLERI, M , DAVIES, A , DROSSMAN, DA , WEBSTER, LR , BECKER, G , (2015) DEFINITIONS AND OUTCOME MEASURES OF CLINICAL TRIALS REGARDING OPIOID-INDUCED CONSTIPATION A SYSTEMATIC REVIEW.JOURNAL OF CLINICAL GASTROENTEROLOGY. VOL. 49. ISSUE 1. P. 9 -16 | 41 | 84% | 13 |
4 | BECKER, G , BADER, S , DURK, T , (2013) METHYLNALTREXONE FOR THE TREATMENT OF OPIOID-INDUCED CONSTIPATION.EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY. VOL. 7. ISSUE 1. P. 13 -26 | 59 | 64% | 11 |
5 | HOLZER, P , (2009) OPIOID RECEPTORS IN THE GASTROINTESTINAL TRACT.REGULATORY PEPTIDES. VOL. 155. ISSUE 1-3. P. 11 -17 | 45 | 74% | 108 |
6 | PERGOLIZZI, JV , RAFFA, RB , PAPPAGALLO, M , FLEISCHER, C , PERGOLIZZI, J , ZAMPOGNA, G , DUVAL, E , HISHMEH, J , LEQUANG, JA , TAYLOR, R , (2017) PERIPHERALLY ACTING MU-OPIOID RECEPTOR ANTAGONISTS AS TREATMENT OPTIONS FOR CONSTIPATION IN NONCANCER PAIN PATIENTS ON CHRONIC OPIOID THERAPY.PATIENT PREFERENCE AND ADHERENCE. VOL. 11. ISSUE . P. - | 40 | 82% | 0 |
7 | SIEMENS, W , GAERTNER, J , BECKER, G , (2015) ADVANCES IN PHARMACOTHERAPY FOR OPIOID-INDUCED CONSTIPATION - A SYSTEMATIC REVIEW.EXPERT OPINION ON PHARMACOTHERAPY. VOL. 16. ISSUE 4. P. 515 -532 | 34 | 87% | 6 |
8 | POULSEN, JL , BROCK, C , OLESEN, AE , NILSSON, M , DREWES, AM , (2015) EVOLVING PARADIGMS IN THE TREATMENT OF OPIOID-INDUCED BOWEL DYSFUNCTION.THERAPEUTIC ADVANCES IN GASTROENTEROLOGY. VOL. 8. ISSUE 6. P. 360 -372 | 50 | 59% | 5 |
9 | ARGOFF, CE , BRENNAN, MJ , CAMILLERI, M , DAVIES, A , FUDIN, J , GALLUZZI, KE , GUDIN, J , LEMBO, A , STANOS, SP , WEBSTER, LR , (2015) CONSENSUS RECOMMENDATIONS ON INITIATING PRESCRIPTION THERAPIES FOR OPIOID-INDUCED CONSTIPATION.PAIN MEDICINE. VOL. 16. ISSUE 12. P. 2324 -2337 | 38 | 75% | 5 |
10 | LEPPERT, W , WORON, J , (2016) THE ROLE OF NALOXEGOL IN THE MANAGEMENT OF OPIOID-INDUCED BOWEL DYSFUNCTION.THERAPEUTIC ADVANCES IN GASTROENTEROLOGY. VOL. 9. ISSUE 5. P. 736 -746 | 30 | 97% | 0 |
Classes with closest relation at Level 1 |